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Zika virus is an enveloped virus with a single-stranded positive-sense RNA genome. The 
Zika virus is a member of the Flaviviridae family of viruses that was discovered to infect humans 
in 1952. The Flavivirus envelope is decorated by many copies of two membrane proteins that 
facilitate viral entry. The virus is primarily transmitted through mosquito bites. Another method 
by which Zika virus could be transmitted is through sexual contact with Zika infected partners or 
from an infected pregnant woman to fetus known as congenital transmission. Infected patients 
suffer from self-limiting febrile illness including headaches, skin rash myalgia, and 
conjunctivitis. Zika virus has a significant impact on pregnancies, causing developmental defects 
in fetal brain that leads to infants born with smaller head size, a disorder known as microcephaly. 
Zika virus has also been linked to the increase of the development of neurological disorder 
known as Guillain-Barre syndrome. Zika virus has been involved in multiple outbreaks around 
the world, beginning in 2007 where the Zika virus infected about 5,000 of the people of Yap 
Island in Micronesia. The following outbreak began between 2013-2014, affecting about 30,000 
people in French Polynesia. In 2015-2016, Zika virus outbreak was reported to affect the 
Americas, where over 30,000 cases and about 4300 microcephaly cases. Upon entry into host 
cells, Zika virus begins to unpack and release the RNA genome to express the viral proteins as 
well as to replicate the RNA genome. Studies have revealed that autophagy, which is a cellular 
mechanism that protects host cells during starvation and pathogenic infections, is associated with 
Zika replication as it may facilitate the replication of the Zika virus. Here, we investigated the 
effects of autophagy in the replication of Zika virus using an autophagy inducer, rapamycin. For 
this study, we used a human trophoblast cell line which is physiologically relevant to congenital 
transmission of Zika virus. To better understand how autophagy is involved in Zika replication in 
xi 
	
trophoblast cells, a knockout was generated on one of the autophagy gene known as ATG12. The 
ATG12 autophagy protein forms a complex with another autophagy protein known as ATG5. 
PCR analysis revealed that the relative Zika viral load was increased in cells treated with 
rapamycin when compared to non-rapamycin treated cells. Consistent with the rapamycin 
treatment results, Zika replication was lower in ATG12-/- than wild type cells. Interestingly, the 
effect of rapamycin on Zika replication was abolished in ATG12-/- cells.  These findings suggest 
that autophagy facilitates Zika replication. Understanding the effects that autophagy imposes on 
the replication of the Zika virus could provide therapeutic opportunities through designing drugs 
that control the autophagy by either entirely blocking the autophagy mechanism or partially in 
patients who have been infected with Zika virus. Another avenue that would benefit from 
controlling autophagy is by strategizing delivery of autophagy blockers to pregnant patients to 
control the severity of developmental disorders in fetuses such as microcephaly.
INTRODUCTION 
1. Background 
 Zika virus (ZIKV) is a member of the Flaviviridae family of viruses that was 
discovered in 1947  (Agrelli, de Moura, Crovella, & Brandão, 2019; Weaver et al., 2016).  
The ZIKV was known to be a threat to public health globally due to the virus being vector-
borne transmitted through mosquito bites (X. Zhang et al., 2017). Additionally, ZIKV 
transmission can also occur through sexual contact with partners infected with ZIKV 
(D’Ortenzio et al., 2016). Infected patients suffer from self-limiting febrile illness including 
headaches, skin rash myalgia, and conjunctivitis (Liu, Shi, & Qin, 2019). ZIKV has a 
significant impact on pregnancies, causing developmental defects in the head that leads to 
infants born with a smaller brain, a disorder known as microcephaly (Vianna et al., 2018; Yu 
et al., 2017). ZIKV has also been linked to a neurological disorder in adults known as 
Guillain-Barre syndrome (GBS), a neuromuscular disorder that results from the 
immunopathogenesis against the peripheral nervous system (Agrelli et al., 2019; Yuki & 
Hartung, 2012). ZIKV has been involved in multiple outbreaks around the world, beginning 
in 2007 where the virus infected about 5,000 of the people of Yap Island in Micronesia. The 
following outbreak began between 2013-2014, affecting about 30,000 people in French 
Polynesia (Agrelli et al., 2019). In 2015-2016, ZIKV outbreak was reported in the Americas, 
where up to 33 countries and territories were affected with around 30,000 ZIKV infection 
cases and over 4300 reported microcephaly cases. (Faria et al., 2016; Petersen, Jamieson, 











Figure 1: Comparison between typical head size and moderate microcephaly and severe microcephaly. 
Originally published in (Petersen et al., 2016)  
 
2. Transmission 
2.1 Transmission by mosquitoes 
ZIKV is an arthropod-borne virus that relies on a mosquito vector to spread (D Musso 
et al., 2014). The transmission of ZIKV is carried mainly by Aedes aegypti mosquitos (Ioos 
et al., 2014). Mosquito transmission of ZIKV virus begins when a mosquito bites an 
individual infected with ZIKV for a blood meal (Abushouk, Negida, & Ahmed, 2016; Didier 
Musso & Gubler, 2016). The mosquito contracts the ZIKV from the infected individual and 
becomes a carrier of the ZIKV. The ZIKV-infected mosquito bites another individual that is 
not infected with ZIKV for a blood meal. The ZIKV-infected mosquito will transmit the 
ZIKV to the individual, infecting the individual with ZIKV. The transmission cycle continues 
when another mosquito that does not carry the ZIKV bites the ZIKV-infected individual 
(Abushouk et al., 2016). 
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2.2 Sexual Transmission 
The transmission of the ZIKV is not only limited to mosquitos; other modes of 
transmission can also deliver the virus to healthy individuals. One of the modes of 
transmission of ZIKV is through sexual contact (Abushouk et al., 2016; Quicke et al., 2016). 
Sexual contact with partners infected with ZIKV has been proved to pass ZIKV to a naive 
individual. The ability of ZIKV to be transmitted sexually is due to the presence of the viral 
particles in the vaginal and seminal fluids (Abushouk et al., 2016; Didier Musso & Gubler, 
2016). 
2.3 Vertical Transmission 
Another mode of transmission is through the passing of the ZIKV from infected 
mothers to their babies. The type of transmission that relies on the mother-to-baby 
transmission is known as vertical transmission or maternal-fetal transmission (Abushouk et 
al., 2016; Liu et al., 2019). The reason for the ZIKV to be transmitted to the fetus of the 
ZIKV -positive mother is that the virus can penetrate the placental barrier and replicate in the 
fetus (Quicke et al., 2016). The presence of the ZIKV particles in the amniotic fluids and in 
the fetus of the mothers infected with ZIKV is evidence of vertical transmission (Quicke et 


















Figure 2: Routes of entry for  Zika virus. Originally published in (Liu et al., 2019) 
 
3. Genome 
ZIKV is a single-stranded RNA virus. The RNA molecule of ZIKV is in a positive-
sense conformation (Abushouk et al., 2016; X. Zhang et al., 2017). The positive-sense 
conformation of RNA molecules in viruses can be processed as a messenger RNA, which is 
subject for translational machinery (Paranjape & Harris, 2010). The process of hijacking the 
host translational machinery allows the ZIKV to express the genes that code for structural 
proteins as well as nonstructural proteins. The structural proteins that are encoded in the 
ZIKV genome are C, PrM, and E proteins. These proteins are responsible for making up the 
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viral particles of the ZIKV. The C protein in ZIKV forms the capsid that houses the genomic 
material of the ZIKV (Shan et al., 2016). The proteins that are encoded by the E gene form 
the glycoprotein envelope that surrounds the ZIKV capsid (Liu et al., 2019; Shan et al., 2016; 
X. Zhang et al., 2017). The PrM gene codes for a protein that works in concert with the E 
protein. Together, the PrM and the E protein form PrM-E heterodimers. The PrM-E 
heterodimers play a major role in the development of immature ZIKV visions (Zhu et al., 
2016). Whereas the non-structural proteins that ZIKV codes for are NS1, NS2A, NS2B, NS3, 
NS4A, 2K, NS4B, and NS5 (Liu et al., 2019; Shafique, 2017). The non-structural proteins 















3.1  Structural proteins 
3.1.1 Capsid 
 There are three structural proteins encoded by the ZIKV genome. From the 5’ end of 
the genome, the C gene, which is the first gene of the structural genes, codes for the capsid 
protein (Fontaine et al., 2018; Liu et al., 2019; Shang, Song, Shi, Qi, & Gao, 2018). The 
capsid is a protein that surrounds the viral genome. One of the roles the capsid protein plays 
is to provide a level of protection to the viral genome from environmental factors 
(Nuanualsuwan & Cliver, 2003). The capsid is also responsible for the delivery of the virus 
into hosts cells and releasing genetic material in the cytoplasm (Bothner, Dong, Bibbs, 
Johnson, & Siuzdak, 1998; Nuanualsuwan & Cliver, 2003). The structure of viruses is 
broadly classified based on the 3-dimensional morphology of the capsid (Baron, 1996). The 
Flaviviridae family of viruses assumes an icosahedral structure (Agrelli et al., 2019; Plevka 
et al., 2011). The capsid protein forms a nucleocapsid when the RNA molecule of the ZIKV 
enters host cells. The nucleocapsid formation occurs as the virus is being assembled for 
budding out of the infected cell to infect neighboring cells (Shang et al., 2018). It has also 
been discovered that the capsid of the ZIKV localizes into the nucleus of host cells during the 
replication of the virus (Fontaine et al., 2018). 
Additionally, the capsid protein of dengue virus, which is another member of the 
Flaviviridae family that is closely related to ZIKV, disrupts the assembly process of 
nucleosomes by binding to the histone protein in the nucleus. Blocking the nucleosome 
assembly of the infected host cells interferes with the host gene expression (Colpitts, Barthel, 
Wang, & Fikrig, 2011). It has also been discovered that the capsid protein of the ZIKV and 
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other members of the Flaviviridae can positively regulate the production of viral particles 
(Rawlinson & Moseley, 2015; Slomnicki et al., 2017). 
3.1.2 Envelope 
 The third protein to be encoded by the ZIKV genome is the envelope protein, which 
surrounds the capsid of the ZIKV. The envelope is composed of glycoprotein protein formed 
as a result of expressing the envelope protein (E). The E protein is crucial for the viral 
infection of host cells. The structure of the E protein allows the virus to bind to host cellular 
receptors and to facilitate fusion with the host’s membrane to release the virus inside the host 
cells (X. Zhang et al., 2017). To enable the virus to survive inside a human host, the 
structural properties of the E proteins can aid the virus in avoiding antibody neutralization 
(X. Zhang et al., 2017).  
The E protein consists of four domains each serving multiple functions (X. Zhang et 
al., 2017). Three domains of the E protein are EDI, EDII, and EDIII (X. Zhang et al., 2017). 
The fourth domain of the E protein is at the base of the structure known as the stem-
transmembrane domain that serves as an anchorage for the E protein domains (Shafique, 
2017). The EDI domain is positioned between the EDII and EDIII domains and serves as a 
scaffold protein that is necessary for maintaining the structural orientations of the overall E 
protein. The EDI domain aids in the viral attachment to the cells and can facilitate 
neurovirulence through the position of conserved residues at Asn154, an N-linked 
glycosylation site. The E protein is also susceptible to conformational changes occurring by 
the EDI domain due to the nature of the pH environment to facilitate the fusion to host cells. 
These residues at the EDI domain pose an additional set of properties that favor the 
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production of the ZIKV particles, as well as an increase in neuroinvasiveness of the virus (X. 
Zhang et al., 2017).  
EDII domain is positioned towards the peripheral part of the E protein, above the EDI 
domain (X. Zhang et al., 2017). This domain, with the aid of the EDI domain, facilitates the 
fusion with the membrane of host cells (Shafique, 2017; X. Zhang et al., 2017). The 
membrane fusion process is carried out through the 98–110 amino acid sequence, which is a 
highly conserved sequence that forms what is known as the fusion loop (X. Zhang et al., 
2017). The fusion loops interact with the membrane of host cells, and the viral membrane as 
the E protein undergoes conformational changes with pH change (Gratton, Agrelli, Tricarico, 
Brandão, & Crovella, 2019; Shafique, 2017; X. Zhang et al., 2017). The consequence of 
fusion between the membrane of the ZIKV and the membrane of host cells is that host cells 
engulf the virus in an endosome. The inside of the endosome will have a very acidic 
environment that induces conformational changes to the ZIKV envelope, facilitating the 
fusion (Agrelli et al., 2019). 
The third domain of the E protein is the EDIII, which is positioned towards the inner 
side of the E protein and is connected to the stem domain (Shafique, 2017). Sulfide-sulfide 
bridges contribute to the stability of the connection to the stem domain (X. Zhang et al., 
2017). The EDIII domain provides sites complementary to cellular receptors to facilitates 
binding. The structure of the EDIII domain is known to play a role in triggering antibodies to 
neutralize the E protein of the ZIKV. This domain is subject to being used for designing 
















Figure 4: Structural domains of envelope protein. (X. Zhang et al., 2017) 
 
3.2 Non-structural protein 
After the viral genome is being released in the cytoplasm of the infected host cell and 
translated into a polyprotein,  the host proteases begin cleaving the polyprotein with the help 
of viral proteases into 10 structural and non-structural proteins (Abushouk et al., 2016; X. 
Zhang et al., 2017). The non-structural (NS) proteins play a crucial role in viral replication as 
well as the participation in virulence and immune evasion. The NS1 protein is one of the 
seven non-structural proteins. The main function of the intracellular NS1 protein is to 
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facilitate the replication process of RNA of the ZIKV (Nogales et al., 2017; Sager, Gabaglio, 
Sztul, & Belov, 2018; Zou et al., 2015). When the NS1 is localized into the lumen of the ER 
it undergoes processing, allowing the NS1 to be associated with the membrane (mNS1) (Asif 
et al., 2017). When the NS1 proteins are either membrane-bound or secreted, the complement 
system activation will be prevented and the Toll-like receptors become activated (Zhu et al., 
2016).  
The NS3, along with the NS2B acting as a cofactor, is responsible for cleavage the 
polyprotein of the ZIKV (Li, Phoo, & Luo, 2014; Zou et al., 2015). The NS3 also participates 
in the replication of the viral RNA by acting as a helicase (Li et al., 2014). The helicase 
activity prevents the formation of dsRNA ahead of the replication complex (Jankowsky & 
Fairman, 2007). Additionally, NS3 also carries a nucleotide phosphatase and RNA 
triphosphatase activities (Li et al., 2014).  
NS4A and NS4B are membrane-integrated proteins that mediated the replication 
process of the Flaviviridae family of viruses (Zou et al., 2015). These two proteins are 
cleaved by the NS3 protein in complex with the NS2A proteins by their protease activity (Li 
et al., 2014). The replication complex formation is facilitated by the NS4A protein when it 
interacts with the vimentin (Zou et al., 2015). Additionally, both NS4A and NS4B proteins 
are also responsible for interfering with the antiviral response in infected cells. Both NS4A 
and NS4B proteins interfere with the JAK/STAT pathway. According to Ma et al, the 
interactions of RLR-MAVS are being blocked by the NS4A, suggesting that the NS4A has a 
suppressive activity towards the RLR pathway. In stem cells, both NS4A and NS4B proteins 
interfere with the signaling of AKT-mTOR. As a result, cellular autophagy mechanism is 
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induced. Links between the interference of AKT-mTOR and microcephaly development have 
been reported (Ma et al., 2018). 
The NS5 protein is also responsible for the replication of the RNA of ZIKV. The NS5 
protein carries an enzymatic activity that is known as RNA-dependent RNA polymerase 
(RdRp) (Lin, Chang, Yu, Liao, & Lin, 2006). The RdRp is a type of polymerase that is 
specialized in replicating RNA molecules (Li et al., 2014; Zou et al., 2015). The NS5 is also 
responsible for the RNA modifications by acting as a methyltransferase and 
guanyltransferase (Grant et al., 2016; Li et al., 2014; Lin et al., 2006). The capping of the 
RNA also allows the RNA to be recognized for translation by the eukaryotic initiation factor 
4 E (eIF4E). The recognition of the viral cap by the eIF4E triggers the host translational 
machinery of the viral RNA (Coutard et al., 2017). NS5 proteins also have negative effects 
on the immunological pathways. The presence of the NS5 proteins in infected cells inhibit 
the signaling for the JAK-STAT pathways that are induced by type I IFN (Ashour et al., 
2010; Best et al., 2005; Grant et al., 2016; Lin et al., 2006).   
4. Replication Cycle: 
Upon the entry of a host cell, ZIKV begins its replication cycle to produce mature 
virion that leaves the infected cells to infect other cells, repeating the cycle (Heinz & Stiasny, 
2017). The replication cycle consists of several events that are crucial for the success of the 
replication cycle. The first step of the replication cycle is the receptor recognition and 
attachment of the host cells by the ZIKV. One of the major components of the envelope in 
the ZIKV is the E protein, which consists of multiple domains known as EDI, EDII, and 
EDIII. The EDIII facilitates the entry of ZIKV by interacting with surface receptors of the 
host cells (Heinz & Stiasny, 2017; X. Zhang et al., 2017). These cell surface receptors are 
12 
	
heparan sulfates, carbohydrate receptors, ribosomal protein SA, and low-density lipoprotein 
receptor-related protein 1 (LRP1) (X. Zhang et al., 2017). The interaction with the cell 
surface receptors induces the cells to uptake the ZIKV through endocytosis, keeping the virus 
in an endosomal vacuole. This process is known as receptor-induced endocytosis (Heinz & 
Stiasny, 2017; X. Zhang et al., 2017). 
Following the ZIKV entry through the induced endocytosis, the virus begins the 
process of membrane fusion (Cann, 2001; Heinz & Stiasny, 2017; Savidis et al., 2016; X. 
Zhang et al., 2017). The membrane fusion allows the envelope of the ZIKV to fuse with the 
endosomal membrane, leading to the uncoating of nucleocapsid and the release of the viral 
genome into the host cytoplasm (Agrelli et al., 2019; Cann, 2001; Savidis et al., 2016; X. 
Zhang et al., 2017). The membrane fusion is triggered by the acidic environment inside the 
endosomal vacuole. This acidic environment induces a conformational change of the E 
protein (Cann, 2001; Savidis et al., 2016; X. Zhang et al., 2017). The fusion process is 
facilitated by the EDII domain of the E protein, which contains a region known as the fusion 
loop (X. Zhang et al., 2017). 
Once the RNA molecule of ZIKV is released in the cytoplasm, the RNA molecule 
begins the translation process (Agrelli et al., 2019). The translation process of ZIKV 
produces the essential structural and non-structural proteins that are essential for the viral 
assembly (Agrelli et al., 2019; X. Zhang et al., 2017). The translational event also produces 
an enzyme crucial to the replication process of ZIKV. This enzyme is RdRp. The RdRp 
utilizes the viral RNA to synthesize new RNA molecules (Cann, 2001; Saiz et al., 2016). The 
RdRp activity is carried out by one of the non-structural proteins NS5 (Lin et al., 2006; Zhao 
et al., 2017). The replication process occurs in the endoplasmic reticulum, where the newly 
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synthesized viral RNA undergoes modifications that prevent their degradation from the 
cytoplasmic environment, as well as allows as the RNA molecules to be recognizable by the 
eIF4E for translational events (Coutard et al., 2017; Grant et al., 2016; Li et al., 2014; Lin et 
al., 2006). 
Once both translational and replicative events are completed, the assembly of ZIKV 
begins (Atif, Azeem, Sarwar, & Bashir, 2016; Saiz et al., 2016). The assembly process of 
ZIKV where the newly RNA molecule assembles with the capsid, PrM, and envelope 
proteins (Heinz & Stiasny, 2017; Saiz et al., 2016; Sikka et al., 2016). The product of the 
assembly is an immature virion. These virions channel through the Golgi apparatus where 
they use the trans-Golgi network (TGN) to utilize the exocytotic pathway (Atif et al., 2016; 
Heinz & Stiasny, 2017; Saiz et al., 2016). The virions then complete their maturation by 
cleaving the PrM by furin enzyme (Heinz & Stiasny, 2017; Saiz et al., 2016). Once the Zika 
virions are packaged and have become fully maturated, they are released by the process of 
























Figure 5: Zika virus replication cycle. Originally published in (Heinz & Stiasny, 2017) 
 
5. Pathogenesis 
 ZIKV pathogenesis in humans causes a range of diseases from self-limiting illness to 
severe disorders (Liu et al., 2019). ZIKV infections through mosquito bites allow entry via 
the skin cells; fibroblast, keratinocytes and immature dendritic cell (Abushouk et al., 2016; 
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Didier Musso & Gubler, 2016; Plourde & Bloch, 2016). The entry of ZIKV is facilitated by 
entry and adhesion factors that assist the viral infection and autophagy induction, which has 
been associated with enhanced viral replication. ZIKV disseminates into other tissues such as 
spleen, brain, spinal cord, kidney, eye and placenta in pregnant women. ZIKV dissemination 
is facilitated using migration into the blood circulation through the lymphatic system 
(Plourde & Bloch, 2016).  
One of the mechanisms ZIKV that contribute to the pathogenesis is the induction of 
apoptotic events in neural progenitor cells. This mechanism may significantly impact brain 
development and leading to microcephaly development (Miner, Diamond, & microbe, 2017). 
GBS development can also occur as ZIKV targets the neural cells. Reports indicate that 
neural illness begins six days before the development of the neurological symptoms, 
suggesting the presence of ZIKV infection in neural cells (Cao-Lormeau et al., 2016).  
6. Autophagy  
As the ZIKV infects cells and undergoes the replicative cycle, cellular pathways that 
induce autophagy formation are triggered (Saiz et al., 2016). Autophagy is a cellular 
mechanism that is initiated due to cellular maintenance or in response to environmental 
stresses (Glick, Barth, & Macleod, 2010; Gratton et al., 2019; Jung, Ro, Cao, Otto, & Kim, 
2010; Rabinowitz & White, 2010). Autophagy mechanisms are classified into three different 
types; macroautophagy, microautophagy, and chaperone-mediated autophagy (Gratton et al., 
2019; Jung et al., 2010; Mizushima & development, 2007; Rabinowitz & White, 2010). 
Macroautophagy, which represents the term autophagy, is a mechanism that forms a double-
membrane vesicle know as an autophagosome (Gratton et al., 2019; Klionsky, Eskelinen, & 
Deretic, 2014; Shoji-Kawata & Levine, 2009; Silvestrini et al., 2018).  This vesicle is formed 
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around cellular waste components that are destined for degradation (cargo). The 
autophagosomal vesicle undergoes membrane fusion with a lysosome, forming 
autophagolysosome (APL) (Ballou & Lin, 2008; Gratton et al., 2019; Klionsky et al., 2014; 
Silvestrini et al., 2018). The fusion with the lysosome causes degradation of the APL’s cargo 
due to high acidity (Glick et al., 2010). Microautophagy is the process of direct lysosomal 
uptake of the cargo where it gets degraded. The chaperone-mediated autophagy pathway 
utilizes the chaperone HS70 and a lysosomal membrane protein 2A (LAMP2A) (Glick et al., 
2010; Mejlvang et al., 2018; Mizushima & development, 2007).  
The process of autophagy is regulated by multiple factors. One of these factors is 
mTOR (Ballou & Lin, 2008; Jung et al., 2010; Ma et al., 2018). mTOR is a member of the 
PIKK, phosphatidylinositol kinase-related kinase (Jung et al., 2010). This kinase 
phosphorylates serine/threonine residues (Ballou & Lin, 2008). Regulation of mTOR activity 
affects the signaling pathways that induce autophagy. The activation of mTOR has a negative 
regulatory effect on the autophagy formation. Activated mTOR inhibits the induction of the 
autophagy. Environmental stress condition alters the activity states of mTOR, blocking their 
functions (Ballou & Lin, 2008; Jung et al., 2010). One of these stressors is starvation. Under 
starvation conditions, cells utilize autophagy to recycle nutrients and misfolded proteins to 
produce precursors necessary for the generation of essential nutrients for survival (Ballou & 
Lin, 2008; Shoji-Kawata & Levine, 2009). 
The formation of the autophagosome requires the assembly of autophagy-related 
genes (ATG) (Wesselborg & Stork, 2015). To date, about 31 ATG proteins have been 
discovered that are associated with autophagosome formation (Glick et al., 2010; Mizushima 
& development, 2007). These ATG proteins work in concert throughout the process of 
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autophagy. For example, ATG17, ATG29, ATG31, and ATG11 proteins are responsible for 
the formation of pre-autophagosome structures (PAS) (Glick et al., 2010; Jung et al., 2010; 
Mizushima & development, 2007). Other ATG proteins, such as ATG8, are responsible for 
the membrane fusion with the lysosome (Jung et al., 2010; Mejlvang et al., 2018; Mizushima 
& development, 2007). Some of the ATG proteins form complexes with other ATG proteins 
in order for them to become functional. An example of ATG complexes is the ATG12-ATG5 
complex, which functions in facilitating the conjugation of ATG8 with 
phosphatidylethanolamine (PE) (Jung et al., 2010). The ATG12-ATG5 conjugate forms a 
complex with ATG16 that aids in the formation of the phagophore, in addition to recruiting 
LC3B-II (Glick et al., 2010). 
Interestingly, autophagy pathways can also be induced in response to intracellular 
pathogens (Rabinowitz & White, 2010; Shoji-Kawata & Levine, 2009). Viral infections 
stress the cell and cause the inhibition of mTOR pathways induces autophagy in the infected 
cells. Viral infections cause the formation of virus-containing autophagic vesicles in an 
attempt to degrade the virus. The antiviral mechanism of autophagy can limit viral 
replications of some viruses, including Sindbis virus, resulting in reduced viral titers in the 
CNS (Gratton et al., 2019).  
The placental immune system utilizes autophagy formation as one of the defensive 
mechanisms used against pathogenic stresses. One of the pathogenic stressors that induce 
autophagy formation is ZIKV.  The induction of autophagy in placental cells infected with 
ZIKV could be triggered due to the expression of the non-structural genes NS4A and NS4B 
(Chiramel & Best, 2018; Ma et al., 2018; S. Miller, Kastner, Krijnse-Locker, Buhler, & 
Bartenschlager, 2007; Sven Miller, Sparacio, & Bartenschlager, 2006; Paul & 
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Bartenschlager, 2015). Reports have indicated that NS4A and NS4B proteins promote 
autophagy formation using the inhibitory Akt-mTOR pathway (Chiramel & Best, 2018). 
Autophagy formation in cells infected with ZIKV seems to act as a pro-viral mechanism 
(Yuan, Zhang, Li, & microbiology, 2017). Recent studies have suggested that autophagy 
formation may facilitate ZIKV replication and transmission (Cao, Parnell, Diamond, & 
Mysorekar, 2017). The autophagic vacuole is thought to provide a protective barrier from the 
immune system (Zhang, Li, Yuan, & microbiology, 2017). ZIKV also is also involved in 
blocking the lysosomal fusion with the autophagosome to prevent its degradation and to 














SPECIFIC AIMS AND HYPOTHESIS 
 In our study, we wanted to evaluate the effect of autophagy on the replication of 
ZIKV in human trophoblasts, which are physiologically relevant to ZIKV vertical 
transmission and fetal infection. To investigate whether the replication of ZIKV is hindered 
by autophagy deficiency, we created an autophagy gene knockout known as ATG12 in a 
human trophoblast cell line. Then, we wanted to see if induction of autophagy by rapamycin, 
an mTOR inhibitor and an autophagy inducer would result in higher viral loads. We 
hypothesized that the use of rapamycin would enhance ZIKV replication. 
Aim: Determining whether the autophagy formation in trophoblast would facilitate the 
replication of ZIKV 
We generated ATG12 gene knockout in trophoblast cells to determine whether 
autophagy deficiency would hinder the replication of ZIKV. We have also treated cells with 
rapamycin to determine if autophagy induction would increase the viral replication of ZIKV 










MATERIALS AND METHODS 
1. Cell culture and virus 
The primary cell line that was used for this study is human placental trophoblast. For 
this experiment, the trophoblast cells were cultured at 37C in a 5% CO2 incubator. The cells 
were cultured in RPMI medium with 10% of FBS and 1% pen-strep antibiotic. Trophoblast 
ATG12 gene knockout (ATG12-/-) was generated and was kindly provided by my lab 
colleague. The ATG12-/- trophoblast cells were cultured in RPMI medium with 10% FBS and 
1% pen-strep antibiotic. The trophoblast cells were incubated at 37ºC in a 5% CO2 incubator. 
Vero cell line was also used in the study for ZIKV propagation. The cells were 
cultured in DMEM medium with 10% FBS and 1% pen-strep antibiotic. Vero cells were 
incubated at 37ºC in the CO2 incubator. 
ZIKV was kindly supplied by one of my lab colleagues. The virus was propagated in 
Vero cells for 72hrs. The ZIKV was stored at -80ºC. 
2. Reagents and antibodies 
 The antibodies used for the western blot analysis were mouse anti-ATG12 (Cat# 
MAB6807) that was purchased from R&D systems; rabbit anti-LC3B (Cat# 2775), and Actin 
(Cat# 8456) were purchased from Cell Signaling Technology (Danvers, MA, United States). 
Rapamycin (Cat# 553210) was purchased from EMD Millipore Corp (Billerica, MA, United 
States). PrimeScript™ RT Reagent Kit (Perfect Real Time) (Cat# RR07A) was purchased 





3. Western blotting 
The Western blot technique was used to confirm that the ATG12 knockout of the 
trophoblast had been generated. The wild type (WT) and the ATG12-/- were incubated until 
the cells were about 90% confluent. The cells were extracted by removing the old medium 
and treating the cells for 1 minute with cold PBS, which then was removed. The cells were 
then dislodged by pipetting fresh medium. Once the cells were suspended in fresh medium, 
the cells were pelleted by centrifugation at 1000 rpm. After removal of the supernatant, the 
isolated cells were lysed with cold lysis buffer and placed on ice. The constituents of the lysis 
buffer included 0.5% NP-40, 50 nM Tris-HCL, pH 7.4, 2 mM EDTA, protease inhibitors and 
150 mM NaCl. The cells were then subjected to centrifugation at 10,000 rpm, and the 
supernatant was collected for western blot analysis. The supernatant was treated with loading 
buffer and subjected to SDS gel electrophoresis. The protein bands generated on the SDS gel 
were transferred to the membrane. The membrane was blocked with 5% milk for 1 hour, then 
probed with anti-ATG12 and anti-LC3 primary antibodies that were purchased from Cell 
Signaling. The membranes were incubated with the primary antibodies overnight at 4°C. The 
antibodies were diluted in 5% milk and the concentration were following manufactures 
specifications. Anti-actin antibodies were used as a control for this experiment. Then, the 
membrane was incubated with secondary antibodies for 1hr at 4ºC. The membrane was then 
treated with a chemiluminescent substrate and was exposed to a film. The film was then 
developed using a film developer. 
4. ZIKV infection and rapamycin treatment 
The WT and ATG12-/- trophoblast cells were cultured to about 90% confluence. The 
medium was removed, cells were washed with cold PBS for 1 minute, and dislodged by 
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applying fresh RPMI medium. WT and ATG12-/- cells were each was seeded in a 24-well 
plate and incubated until reaching confluence. The medium was then removed, and the cells 
were treated with ZIKV in all wells for 3 hours. The medium containing the virus was then 
removed and replaced with a fresh RPMI medium. Half of the wells in the 24-well plate were 
treated with 100 nM rapamycin, while the other half were treated with 50 nM rapamycin for 
3 hours. The medium was replaced with fresh medium thatalso contained rapamycin. The 
cells in the 24-well plate were incubated at 37°C in a CO2 incubator for 24hrs or 48hrs . At 
these time points, the WT and the ATG12-/- cell samples were lysed using TRK lysis buffer. 
5. RNA extraction and qPCR analysis 
Total RNA was extracted from the lysed WT or the ATG12-/- trophoblast cells using 
the E.Z.N.A. Total RNA Kit I by OMEGA. The isolated RNA samples were subjected to RT-
PCR using the PrimeScript™ RT Reagent Kit (Perfect Real Time) to generate cDNA. The 
cDNA samples were then subjected to qPCR analysis. The targets for the cDNA samples 
consisted of ZIKV, IFNB1, and Actin. The ZIKV primers used were 5’ 
CCGCTGCCCAACACAAG-3’ and 5’CCACTAACGTTCTTTTGCAGACAT-3’.  The 
IFNB1 primer (Hs01077958_s1) used in the qPCR analysis was purchased from 
ThermoFisher Scientific. The viral load was calculated using the -ΔΔCT method and was 








1. Confirmation of ATG12 Gene Knockout in Trophoblast Cells 
 The trophoblast gene knockout of ATG12 was generated previously by a lab 
colleague. To determine whether the gene has been deleted successfully, Western blot 
analysis was performed on WT and ATG12-/-. At about 55 kDa, we observed a band in the 
WT lane. The anti-ATG12 antibody was detected at in WT cells. The anti-ATG12 antibody 
was not detected at the same molecular weight, 55 kDa in ATG12-/- cells. This suggests 
observation suggests that the ATG12 protein was absent in ATG12-/- cells, confirming a 
successful gene knockout of the ATG12.  
To further confirm that the ATG12 gene was successfully knocked out, another 
autophagy-related protein that is associated with the ATG12-ATG5 conjugates was 
investigated. This protein is LC3B-II. Anti-LC3 antibody was used to detect the presence of 
LC3B-I and LC3B-II proteins. The Anti-LC3B antibody detected the presence of LC3B-I at 
16 kDa in the WT cells. At 14 kDa molecular weight, the anti-LC3B antibody did not 
detected the presense of LC3B-II in the ATG12-/- cells. The absence of LC3B-II protein is an 
indication of defects in ATG12-ATG5 conjugate as they are required for the lipidation of the 
LC3B-II. These observations further confirmed that ATG12 gene was successfully knocked 
out in trophoblast cells. (Fig. 7)  
2. ZIKV Infection of ATG12 Deficient Trophoblast Cells 
 To investigate the effects of autophagy formation on the replication of ZIKV, we 
transfected both WT and ATG12-/- trophoblast cells with ZIKV. The total RNA was 
extracted from both WT and ATG12-/- trophoblast cells at three time points; 24, 48, and 
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72hrs. RT-PCR was performed to synthesize cDNA. The cDNA samples were then subjected 
to qPCR analysis. We have used primers targeting ZIKV, and IFNB1 to investigate the viral 
load in response to autophagy deficiency, and to correlate the antiviral response to ZIKV 
load. The qPCR analysis revealed that there is a significant decrease in the relative viral load 
in response to autophagy deficiency at both 24 and 48hrs post-ZIKV infection when 
compared to the WT with a P < 0.01. Past 48hrs, the relative viral load began to decline 
gradually. These findings suggest that autophagy-deficiency hindered the ability of ZIKV to 
replicate efficiently (Fig. 8). 
 The relative IFNB1 levels were significantly lower in ATG12-/- cells in the first 48hrs 
post the ZIKV infection with P < 0.05. At 72hrs post-infection, the IFNB1 levels began to 
decline gradually. The IFNB1 patterns are correlated with the relative viral load of ZIKV, 
likely as a secondary result of reduced viral replication (Fig. 9). 
3. ZIKV Infection of Trophoblast Cells Treated with Rapamycin 
 Now that we have confirmed that autophagy deficiency in trophoblast cells 
significantly reduced the relative viral load, we wanted to determine whether autophagy 
induction by rapamycin in trophoblast cells would increase the relative viral load in 
trophoblast cells. Rapamycin is an mTOR inhibitor that induces autophagy formation. To 
investigate the of rapamycin on ZIKV viral load, we treated both WT and ATG12-/- with two 
different concentrations of rapamycin; 50 nM or 100 nM. The total RNA was extracted for 
PCR analysis at 24 and 48hrs. The qPCR analysis revealed that rapamycin treatment in 
trophoblast cells that at 24hrs post-infection, there was an increase in the relative viral load of 
ZIKV in WT cells treated with 100 nM rapamycin. The relative viral load of ZIKV in WT 
trophoblast cells treated with 50 nM rapamycin did not increase as much compared to WT 
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cells treated with 100 nM rapamycin. Interestingly, both 50 nM and 100 nM rapamycin 
treatment did not increase the viral load in ATG12-/- trophoblast cells (Fig. 10). However, at 
48hrs, similar ZIKV loads were observed in both WT and ATG12-/- trophoblast cells that had 
been treated with either 50 nM or 100 nM rapamycin. These findings suggest that 100 nM of 
rapamycin treatment was sufficient enough to induce autophagy formation in WT trophoblast 
cells, thus increasing the viral load of ZIKV. The low relative viral load in 50 nM rapamycin-
treated WT trophoblast cells may be an indication of an insufficient concentration of 
rapamycin to induce enough autophagy formation. The findings at 48hrs indicate that the 
ZIKV replication does not rely solely on the process of autophagy (Fig. 11).  
 We also trophoblast cells investigated the IFNB1 levels in ZIKV infections in 
response to rapamycin treatment. At 24hrs post infection, IFNB1 levels were elevated in WT 
at both 50 nM and 100 nM rapamycin concentrations when compared to the ATG12-/- 
trophoblast cells (Fig. 12). At 48hrs, WT cells treated with 100 nM rapamycin displayed an 
increase in IFNB1 levels. These findings were consistent with the IFNB1 patterns in Figure 9, 













Figure 7: ATG12 gene was successfully deleted in trophoblast cells. Cellular proteins of trophoblast were 
separated on SDS-PAGE.  Membranes were probed for the presence of ATG12, LC3BI/II, and Actin proteins. 
The first lane represents WT trophoblast cell lysate. The second lane contains ATG12-/- trophoblast cell lysate. 
Anti-ATG12 did not detect a product in ATG12-/- at 55 kDa, which would correspond to the ATG12-ATG5 
conjugate. Similarly, anti-LC3B antibody did not detect LC3B-II in ATG12-/- cells.  In summary, this Western 
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Figure 8: ZIKV viral load was decreased in ATG12-/- cells. The relative viral load in WT trophoblast cells is 
significantly higher in WT than in ATG12-/- trophoblast cells during the first 48hrs. The viral load then begins 
to drop after 48hrs of the ZIKV infection. The plots indicate the mean of three replicates and error bars indicate 
































Figure 9: IFNB1 levels decreased in ATG12-/- cells in response to ZIKV. The relative levels of the IFNB1 in 
response to the viral infection is at basal levels 24hs post infection. The IFNB1 levels begin to rise significantly 
48 and 72hrs post infection. The plots indicate the mean of three replicates and error bars indicate the standard 




















Figure 10: ZIKV viral load increased in WT trophoblast cells in response to 100 nM rapamycin 24hrs 
post infection. Both WT and ATG12-/- were treated with either 50 nM or 100 nM of rapamycin drug. WT cells 
treated with 100 nM of rapamycin display elevated levels of relative ZIKV viral load when compared to the 
ATG12-/- at 24hrs post infection. There is a trend towards significance in the readings that was not achieved 
due to the small sample size. Columns indicate the mean of three replicates and error bars indicate the standard 




















Figure 11: Similar ZIKV viral load in both cells treated with 50 nM or 100 nM rapamycin 48hrs post 
infection. At 48hrs, the relative viral load of ZIKV in WT and ATG12-/- treated with either 50 nM or 100 nM 
of Rapamycin begins to reach equilibrium. There is a trend towards significance in the readings that was not 
achieved due to the small sample size. Columns indicate the mean of three replicates and error bars indicate the 





















Figure 12: IFNB1 levels increased in cells infected with ZIKV in response to 50 nM and 100 nM 
rapamycin 24hrs post infection. Both WT and ATG12-/- were treated with wither 50 nM or 100 nM of 
Rapamycin drug. At both dosages of Rapamycin, IFNB1 levels in WT were higher than ATG12-/- at 24hrs post 
infection.. There is a trend towards significance in the readings that was not achieved due to the small sample 
size. Columns indicate the mean of three replicates and error bars indicate the standard deviation. This 



















Figure 13: Further increase in IFNB1 levels in cells infected with ZIKV in response to 100 nM rapamycin 
48hrs post infection. At 48hrs, the IFNB1 levels in WT cells treated with 100 nM rapamycin increased by one-
fold. There is a trend towards significance in the readings that was not achieved due to the small sample size. 
Columns indicate the mean of three replicates and error bars indicate the standard deviation. This experiment 






 Our primary goal in this study was to investigate the role of autophagy formation in 
trophoblast cells in the replication of the ZIKV. We have created a scenario for the ZIKV 
replication where the target cells were incapable of establishing autophagy. Then we 
investigated how autophagy formation would impact the viral replication of ZIKV. 
 The fetus is protected from pathogenic infections through the placental barrier. When 
a pathogen invades the placental barrier and infect placental cells, an immune response 
becomes triggered, and other protective mechanisms such as autophagy are activated. During 
pathogenic infections, autophagy formation captures the pathogen and fuses with the 
lysosomal compartment to degrade the pathogen. In our study, we have confirmed that 
autophagy formation provides a favorable environment for ZIKV to replicate. Generation of 
a gene knockout of ATG12, which is crucial for the formation of the autophagophore, has 
demonstrated the significance of autophagy in enhancing ZIKV replication in trophoblast 
cells. Our observations confirm previous studies conducted with a different autophagy-
related gene, AT16L1. Additionally, our findings further strengthen the current 
understanding regarding autophagy mechanism and ZIKV replication. 
 Autophagy is a crucial mechanism of cell survival. ZIKV infections take advantage of 
the autophagosome formation. ZIKV has been known to induce autophagy once the NS4A 
and NS4B are translated. NS4A and NS4B play a role in inducing autophagy in cells (Ma et 
al., 2018). Our experiments have expanded our knowledge and understanding regarding 
autophagy induction. We induced autophagy using a drug known as rapamycin. Rapamycin 
is an mTOR inhibitor and an autophagy inducer. Autophagy induced with rapamycin resulted 
in higher ZIKV viral load in WT trophoblast cells. Our results have confirmed that 
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autophagy formation facilitates the viral replication of ZIKV. The effect of rapamycin on 
ZIKV replication was abolished in ATG12 deficient trophoblast cells, which was expected 
due to the absence of autophagophore formation. Rapamycin may induce autophagy, but the 
cells were not able to form a robust autophagophore structure that surrounds the ZIKV. 
Therefore, ZIKV was not able to replicate efficiently. 
 Due to the significant impact of ZIKV on placental and neural cells, therapeutic 
interception is required to limit viral replication of ZIKV in the fetus and neuronal cells. Our 
study demonstrates an alternative approach to limiting the viral replication of ZIKV in 
trophoblast cells through autophagy regulation. Currently, multiple studies have 
demonstrated promising results using drugs to limit the ZIKV replication in placental 
trophoblast cells (Bayer et al., 2016; Delvecchio et al., 2016; Elfiky, 2016; Sacramento et al., 
2017; Xu et al., 2016; Zmurko et al., 2016). Combining these drugs with autophagy 
inhibitors might provide a stronger suppression to the viral replication of ZIKV and may 
limit the possibility of maternal-placental transmission. More studies are required to 
investigate the combinational therapies using these promising anti-ZIKV drugs with 
autophagy blockade drugs that target essential autophagy-related genes at both in vitro and in 
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